Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance
Johnathan Oh, M. Barve, N. Senzer, P. Aaron +9 more
2020Gynecologic Oncology Reports24 citations Open access
Semantic Scholar

